A5040353259- Cutaneous Melanoma Detection and Management
- Sperm and Testicular Function
- Ovarian function and disorders
- Probiotics and Fermented Foods
- Protein Hydrolysis and Bioactive Peptides
- Reproductive Biology and Fertility
- Nonmelanoma Skin Cancer Studies
- Traditional Chinese Medicine Studies
- Food composition and properties
- Reproductive Health and Technologies
- Microbial Metabolites in Food Biotechnology
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Assisted Reproductive Technology and Twin Pregnancy
- Psychological Treatments and Assessments
- Cutaneous lymphoproliferative disorders research
- Facial Rejuvenation and Surgery Techniques
- Mindfulness and Compassion Interventions
Universidade Estadual de Campinas (UNICAMP)
2012-2023
Hôpital Antoine-Béclère
1995
Pôle de Recherche pour l'Organisation et la Diffusion de l'Information Géographique
1994
cutaneous melanoma (MC) is a malignant neoplasm derived from melanocytic cells with an aggressive behavior. It usually associated the multifactorial interaction of genetic susceptibility and environmental exposure, ultraviolet radiation. Despite advances in treatment, disease remains relentless poor prognosis. Sentinel lymph node (SLN) biopsy technique used to screen patients need dissection.to correlate tumor burden SLN mortality undergoing biopsy.the medical records histological slides MC...
RESUMO Introdução: o melanoma cutâneo (MC) é uma neoplasia maligna de comportamento agressivo, derivada das células melanocíticas, geralmente causado pela associação interação da suscetibilidade genética e a exposição ambiental. A biópsia do linfonodo sentinela (LNS) um procedimento utilizado para rastreamento doentes com necessidade ou não linfadenectomia, diminuindo paciente cirurgias maiores. Objetivos: correlacionar carga tumor no LNS mortalidade pacientes MC. Métodos: foram examinados...
Determinar los efectos de la incubación espermatozoides (spz) con Pentoxifilina (PF) sobre las características movimiento pacientes normo y oligoastenospérmicos el resultado su utilización en fecundación in vitro (FIV) por oligoastenospermia severa.